All Phenotypes Epn2<tm1Ocr> MGI Mouse

Phenotypes associated with this allele

Allelic Composition	Epn2^tm1Ocr/Epn2^tm1Ocr
Genetic Background	B6.129X1-Epn2^tm1Ocr

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epn2^tm1Ocr mutation (0 available); any Epn2 mutation (73 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

normal phenotype

no abnormal phenotype detected ( J:151951 )

• viable and fertile with no gross abnormalities

Allelic Composition	Epn1^tm1.1Wami/Epn1^tm1.1Wami Epn2^tm1Ocr/Epn2^tm1Ocr Tg(Cdh5-cre/ERT2)CIVE23Mlia/0 Tg(TRAMP)8247Ng/0
Genetic Background	involves: 129X1/SvJ * C57BL/6 * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epn1^tm1.1Wami mutation (0 available); any Epn1 mutation (32 available)
Epn2^tm1Ocr mutation (0 available); any Epn2 mutation (73 available)
Tg(Cdh5-cre/ERT2)CIVE23Mlia mutation (0 available)
Tg(TRAMP)8247Ng mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Reduced tumor growth in Epn1^tm1.1Wami/Epn1^tm1.1Wami Epn2^tm1Ocr/Epn2^tm1Ocr Tg(Cdh5-cre/ERT2)CIVE23Mlia/0 Tg(TRAMP)8247Ng/0 mice

mortality/aging

increased tumor-free survival time ( J:193966 )

• tamoxifen-treated mice exhibit decreased mortality compared with Tg(TRAMP)8247Ng control mice

neoplasm

decreased tumor growth/size ( J:193966 )

• tamoxifen-treated mice develop smaller tumors compared with Tg(TRAMP)8247Ng control mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Disrupted endothelial junctions in tumor vessels of Epn1^tm1.1Wami/Epn1^tm1.1Wami Epn2^tm1Ocr/Epn2^tm1Ocr Tg(Cdh5-cre/ERT2)CIVE23Mlia/0 mice

mortality/aging

decreased susceptibility to induced morbidity/mortality ( J:193966 )

• tamoxifen-treated mice transplanted with GL261glioma cells survive longer than with control mice

neoplasm

abnormal tumor vascularization ( J:193966 )

• tamoxifen-treated mice transplanted with Lewis Lung carcinoma (LLC) cells exhibit disorganized, fragile, immature, enlarged and leaky tumor vessels compared with control mice

• however, treatment with a VEGFR2 kinase inhibitor restored tumor vasculature

decreased incidence of tumors by chemical induction ( J:193966 )

• tamoxifen-treated mice subjected to AOM/DSS exhibit reduced tumor incidence and decreased tumor growth compared with control mice

decreased tumor growth/size ( J:193966 )

• tamoxifen-treated mice transplanted with Lewis Lung carcinoma (LLC) cells develop fewer, smaller tumors that grow at a slower rate compared with control mice

• tamoxifen-treated mice transplanted with GL261glioma cells develop smaller tumors compared with control mice

• tamoxifen-treated mice subjected to AOM/DSS exhibit reduced tumor incidence and decreased tumor growth compared with control mice

cardiovascular system

abnormal tumor vascularization ( J:193966 )

• tamoxifen-treated mice transplanted with Lewis Lung carcinoma (LLC) cells exhibit disorganized, fragile, immature, enlarged and leaky tumor vessels compared with control mice

• however, treatment with a VEGFR2 kinase inhibitor restored tumor vasculature

abnormal vascular endothelial cell migration ( J:193966 )

• endothelial cells treated with tamoxifen exhibit enhanced VEGF-stimulated migration compared with control cells

abnormal vascular endothelial cell physiology ( J:193966 )

• endothelial cells treated with tamoxifen exhibit disrupted endothelial junctions compared with control cells

increased vascular endothelial cell proliferation ( J:193966 )

• endothelial cells treated with tamoxifen exhibit enhanced VEGF-stimulated proliferation compared with control cells

increased vascular permeability ( J:193966 )

• of tumor vasculature in tamoxifen-treated mice transplanted with Lewis Lung carcinoma (LLC) cells

• however, vascular permeability of blood vessels in major organs is normal

cellular

abnormal vascular endothelial cell migration ( J:193966 )

• endothelial cells treated with tamoxifen exhibit enhanced VEGF-stimulated migration compared with control cells

increased vascular endothelial cell proliferation ( J:193966 )

• endothelial cells treated with tamoxifen exhibit enhanced VEGF-stimulated proliferation compared with control cells

homeostasis/metabolism

decreased incidence of tumors by chemical induction ( J:193966 )

• tamoxifen-treated mice subjected to AOM/DSS exhibit reduced tumor incidence and decreased tumor growth compared with control mice

Allelic Composition	Epn1^tm1.1Wami/Epn1^tm1.1Wami Epn2^tm1Ocr/Epn2^tm1Ocr Tg(Cdh5-cre)7Mlia/0
Genetic Background	involves: C57BL/6J * FVB/N

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Reduced tumor growth in Epn1^tm1.1Wami/Epn1^tm1.1Wami Epn2^tm1Ocr/Epn2^tm1Ocr Tg(Cdh5-cre/ERT2)CIVE23Mlia/0 and Epn1^tm1.1Wami/Epn1^tm1.1Wami Epn2^tm1Ocr/Epn2^tm1Ocr Tg(Cdh5-cre)7Mlia/0 mice

neoplasm

decreased tumor growth/size ( J:193966 )

• mice transplanted with Lewis Lung carcinoma (LLC) cells develop fewer tumors that grow at a slower rate compared with control mice

Allelic Composition	Epn1^tm1Ocr/Epn1⁺ Epn2^tm1Ocr/Epn2^tm1Ocr
Genetic Background	B6.129X1-Epn1^tm1Ocr Epn2^tm1Ocr

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epn1^tm1Ocr mutation (0 available); any Epn1 mutation (32 available)
Epn2^tm1Ocr mutation (0 available); any Epn2 mutation (73 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

decreased survivor rate ( J:151951 )

• not as severe as in mice heterozygous for the Epn2 mutation and homozygous for the Epn1 mutation

premature death ( J:151951 )

• not as severe as in mice heterozygous for the Epn2 mutation and homozygous for the Epn1 mutation

growth/size/body

slow postnatal weight gain ( J:151951 )

• not as severe as in mice heterozygous for the Epn2 mutation and homozygous for the Epn1 mutation

Allelic Composition	Epn1^tm1Ocr/Epn1^tm1Ocr Epn2^tm1Ocr/Epn2⁺
Genetic Background	B6.129X1-Epn1^tm1Ocr Epn2^tm1Ocr

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

decreased survivor rate ( J:151951 )

premature death ( J:151951 )

• percentage of mice surviving to 10 months of age is reduced

growth/size/body

slow postnatal weight gain ( J:151951 )

reproductive system

reduced fertility ( J:151951 )

Allelic Composition	Epn1^tm1Ocr/Epn1^tm1Ocr Epn2^tm1Ocr/Epn2^tm1Ocr
Genetic Background	B6.129X1-Epn1^tm1Ocr Epn2^tm1Ocr

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Major developmental defects in Epn1^tm1Ocr/Epn1^tm1Ocr Epn2^tm1Ocr/Epn2^tm1Ocr embryos

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:151951 )

• die between E9.5 and E11.5

embryo

abnormal embryo turning ( J:151951 )

• fail to undergo axial rotation in the sagital plane

embryonic growth arrest ( J:151951 )

• arrest by E9.5

decreased embryo size ( J:151951 )

• at E9.0

abnormal neural tube morphology ( J:151951 )

• at E9.0 picnotic cells are seen in the neural tube

open neural tube ( J:151951 )

• at E9.0

abnormal somite development ( J:151951 )

abnormal somite shape ( J:151951 )

• somites that do form are irregular in size and shape

abnormal somite size ( J:151951 )

• somites that do form are irregular in size and shape

incomplete somite formation ( J:151951 )

• severely impaired somitogenesis resulting in a reduction in the number of somites formed by E9.5

absent placental labyrinth ( J:151951 )

• at E9.0

abnormal vitelline vascular remodeling ( J:151951 )

• lack large vitelline vessels and the sinusoids are larger and dilated at E9.0 indicating failure to remodel the vascular plexus

nervous system

abnormal brain vasculature morphology ( J:151951 )

• at E9.0, vessels in the telencephalic region fail to form finely branched trees, instead a coarse network of uniformly sized vessels is present

abnormal neural tube morphology ( J:151951 )

• at E9.0 picnotic cells are seen in the neural tube

open neural tube ( J:151951 )

• at E9.0

cardiovascular system

abnormal blood vessel morphology ( J:151951 )

• at E9.0 in the intersomitic region, vessels are only present in areas where somites develop and these vessels are disorganized compared to controls

abnormal brain vasculature morphology ( J:151951 )

• at E9.0, vessels in the telencephalic region fail to form finely branched trees, instead a coarse network of uniformly sized vessels is present

abnormal developmental vascular remodeling ( J:151951 )

• defects in angiogenic vascular remodeling

thin ventricular wall ( J:151951 )

• atrophic ventricular wall seen at E9.5

cellular

cellular phenotype ( J:151951 )

N	• no defects in proliferation or clathrin mediated endocytosis are detected in MEFs in contrast results from previous experiments using Epn1 knockdown cells

growth/size/body

decreased embryo size ( J:151951 )

• at E9.0

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/30/2024 MGI 6.23